Third Rock Ventures GP IV, L.P.
SEC CIK 1688326 · EDGAR
BoughtSold
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Beckman Daniella | CFO | — | $126.6K |
| 5 | Ketchum John B | Dir | — | — |
| 6 | Peters Malte | Pres, CEO, Dir | — | — |
| 7 | Rothenberg Mace | Dir | — | — |
| 8 | Gall Matthew | CFO | — | — |
| 9 | Lee Sung | Dir | — | — |
| 10 | Calhoun Lesley Ann | Dir | — | — |
Third Rock Ventures GP IV, L.P. made no open-market trades at TNGX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-26 | 2025-08-22 | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures GP IV, L.P. | 10% | S - Sale | $7.00 | -302.2K | 15.46M | -2% | -$2.12M | |
| 2025-08-21 | 2025-08-19 | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures GP IV, L.P. | 10% | S - Sale | $7.01 | -1.10M | 15.76M | -7% | -$7.71M | |
| M | 2024-08-20 | 2024-08-16+ | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures GP IV, L.P. | 10% | S - Sale | $9.95 | -285.0K | 17.20M | -2% | -$2.84M |
| M | 2024-08-01 | 2024-07-30+ | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures GP IV, L.P. | 10% | S - Sale | $9.86 | -235.0K | 17.53M | -1% | -$2.32M |
| M | 2024-07-24 | 2024-07-22+ | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures GP IV, L.P. | 10% | S - Sale | $9.78 | -387.7K | 18.07M | -2% | -$3.79M |
| 2024-07-18 | 2024-07-17 | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures GP IV, L.P. | 10% | S - Sale | $9.79 | -550.2K | 18.65M | -3% | -$5.39M | |
| 2021-08-26 | 2021-08-25 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Third Rock Ventures GP IV, L.P. | 10% | J - Other | — | -1.25M | 6.76M | -16% | — |
Purchase Sale Sale after option exercise All abbreviations